Boehringer Explores ‘Dark Antigens’ With Enara In Potential $1bn Deal

Covers Novel Cancer Immunotherapy Targets And Therapies

 
• By Andrew McConaghie
  
Cancer cell and T cells
'Dark antigens' are hidden targets for immunotherapies which could be revealed thanks to new drug discovery techniques
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip